Tatyana V. Gabrusskaya

Tatyana V. Gabrusskaya

Auto-generated profile, based on publicly available information

Tatyana V. Gabrusskaya

Saint Petersburg State Pediatric Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2017 in Pediatrician (St. Petersburg)
Verified
Journal Article
Open access
PDF file
TGTatiana V Gabrusskaia
Tatiana V Gabrusskaia
Mikhail KostikMikhail Kostik
Mikhail Kostik
YNYulia A Nasyhova
Yulia A Nasyhova
MRMaria O Revnova
Maria O Revnova
DKDiana A Kuzmina
Diana A Kuzmina
Evaluation of bone mineralization and bone metabolism in children with inflammatory bowel disease (IBD) in accordance with TaqI-polymorphic genotypes of vitamin D receptor (VDR) has been performed in this study. 83 children (38 girls and 54 boys) with IBD (60 with Crohn’s disease, 23 with ulcerative colitis) have been included in the study. Mean age was 13.0 years (11.0; 15.5). All patients have active phase of the disease. Bone mineral density (BMD) of lumbar spine (DEXA) have been assessed in all children. Level of serum osteocalcin (OC) as a marker of osteosynthesis, C-terminal telopeptides (CTT) as a marker of osteoresorbtion, parathyroid hormone (PTH), serum calcium, phosphorus, alkaline phosphatase and 25(OH) vitamin D was measured to evaluate bone metabolism. Molecular-genetic tests: analysis of TaqI (rs731236) polymorphism of vitamin D receptor gene (VDR) was perfomed by polymerase chain reaction with following restriction analysis. Association between molecular markers of VDR gene and bone metabolism and mineralization disturbances have been found. TT genotype of VDR gene was associated with tendency to decrease of linear growth velocity, low linear growth, decrease in osteosynthesis and increase of osteoresorbtion in this group of children. TT-genotype of TaqI-polymorphism of VDR gene can be assessed as a risk factor of bone metabolism disturbances in children with both Crohn’s disease and ulcerative colitis. C allele seems to have protective role in this group.

19 March 2016 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Closed access
ARAnna A. Roppelt
Anna A. Roppelt
DYDarya V. Yukhacheva
Darya V. Yukhacheva
NMNatalia V. Myakova
Natalia V. Myakova
NSNadezhda V. Smirnova
Nadezhda V. Smirnova
YSYuliya Skvortsova
Yuliya Skvortsova
ASAnna Yu. Shcherbina
Anna Yu. Shcherbina
X-Linked lymphoproliferative syndrome (XLP) is a primary immunodeficiency characterized by atypical reaction to Epstein-Barr virus (EBV), resulting in the development of hemophagocytosis, disgammaglobulinemia, and, depending on the syndrome type, malignant lymphoproliferation. Three types of XLP are known. XLP type 1 is a result of mutation in the SH2D1A gene encoding SAP adapter molecule. This XLP type is characterized by predisposition to EBV infection, hemophagocytic lymphohistiocytosis (HLH), disgammaglobulinemia, and malignant lymphoproliferation. XLP type 2 is similar to XLP type 1 by some clinical manifestations, such as predisposition to EBV infection and high risk of HLH, but differs from type 1 by the pathogenesis, development of hemorrhagic colitis, and absence of lymphomas. The clinical manifestations of XLP type 2 develop as a result of defects in XIAP gene, also known as BIRC4 gene, encoding an antiapoptotic protein. XLP type 3, caused by loss-of-function _ mutations in the gene encoding magnesium transporter 1 (MAGT1), has been recently discovered. In addition, several autosomal recessive syndromes with a similar XLP clinical manifestation - EBV-associated lymphoproliferation, with ITK, CD27, and CORO1A genes defects, are known. Clinical case reports of the most incident XLP types 1 and 2 are presented.

20 September 2024 in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
VGVictoria A. Glushkova
Victoria A. Glushkova
APAleksei V. Podkamenev
Aleksei V. Podkamenev
TGTatyana V. Gabrusskaya
Tatyana V. Gabrusskaya
ГВГабрусская Татьяна Викторовна
Габрусская Татьяна Викторовна
Crohn’s disease is an inflammatory bowel disease with a chronic recurrent course and a high risk of complications. Crohn’s disease prevalence has been increasing. Despite the era of biological therapy and new therapeutic approaches in the treatment of Crohn’s disease, the role of surgical treatment remains high. This study aimed to analyze the current trends and approaches of surgical treatment localized lesions of ileocecal zone in children with Crohn’s disease. The scientific databases eLibrary, GoogleScholar, MEDLINE, and Embase were searched. The search time interval was 2017–2024. In several recent articles, a trend toward early ileocecal resection in patients with Crohn’s disease was noted. According to some studies in adults, this approach is an alternative option for medical treatment. The advantages of early surgical approach includes decreased surgical complication level, improving the quality of life and reducing the cost of treatment. The timing of early surgical intervention varies. Notably, Crohn’s disease in children has more aggressive character, and early surgical intervention may not only create a therapeutic window of opportunity to control Crohn’s disease but also contribute to improving the long-term results of Crohn’s disease treatment. The role of surgical technique is being studied (the need to include a mesentery with fat wrapping into a resection area or not), the effect of the type of anastomosis on relapse of Crohn’s disease. Analysis of the safety of Kono-S anastomosis and its impact on development recurrence has shown a number of advantages over traditional anastomosis. However, its application in the practice of pediatric surgeons remains isolated. Similar studies are required in children to determine the optimal strategy for the treatment of Crohn’s disease in ileocecal region (determining the role of surgical treatment and type of anastomosis in achieving long-term and deep remission), preventing recurrence of Crohn’s disease and repeated intestinal resections.

11 April 2024 in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
VGVictoria A. Glushkova
Victoria A. Glushkova
APAleksey V. Podkamenev
Aleksey V. Podkamenev
TGTatyana V. Gabrusskaya
Tatyana V. Gabrusskaya
ГВГабрусская Татьяна Викторовна
Габрусская Татьяна Викторовна
In the last decade, the incidence of inflammatory bowel disease in children has been increasing. Some studies have reported the development of Crohn’s disease in patients with Hirschsprung disease and Hirschsprung-associated enterocolitis. Suggestions have been made about the possible causes of the development of Crohn’s-like lesions after intestinal resection in early childhood. This study aimed to summarize information about Hirschsprung-associated Crohn’s disease and Crohn’s-like lesions after surgical treatment of Hirschsprung disease. The search was carried out in scientific databases of eLibrary, PubMed, ScienceDirect, and Google Scholar. The search time interval was 2000–2023. Fourteen articles dedicated to Hirschsprung-associated Crohn’s disease were identified. Common pathogenesis factors in inflammatory bowel diseases and Hirschsprung-associated enterocolitis were identified, such as microbiota disturbance and chronic inflammation. Predisposing factors for pathological immune response to dysbiosis and incidence of enterocolitis included enteric nervous system dysfunction, impaired neuroimmune regulatory mechanisms, general immunological disturbance, and “immaturity” and abnormality of the barrier function of the intestinal mucosa. The “classic form” of Crohn’s disease may not develop in patients with Hirschsprung disease and recurrent attacks of enterocolitis but Crohn’s-like lesions. Persistent functional or organic obstruction after surgical treatment of Hirschsprung disease enhances the negative effect of predisposing factors, leading to chronic inflammation of the intestinal mucosa. Delayed occurrence of Hirschsprung-associated enterocolitis is a predisposing factor for the development of chronic inflammation. When Hirschsprung-associated enterocolitis occurs repeatedly, endoscopic assessment should be performed for the exclusion of Crohn’s disease and chronic inflammatory changes in the anastomosis area for treatment selection.

16 December 2022 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TGT.V. Gabrusskaya
T.V. Gabrusskaya
EKE.A. Kornienko
E.A. Kornienko
MRM.O. Revnova
M.O. Revnova
E(Elizaveta Makarova (Lapina)
Elizaveta Makarova (Lapina)
NUN.B. Ulanova
N.B. Ulanova
EFE.Y. Felker
E.Y. Felker
A clinical case of mitochondrial neurogastrointestinal encephalopathy (MNGIE), a rare autosomal recessive multisystem disease caused by TYMP gene mutations and thymidine phosphorylase (TP) deficiency, is presented. Authors draw the specialists’ attention to the complexity of making a diagnosis and the importance of an interdisciplinary approach in the diagnosis and management of such patients with the purpose of increasing the pediatric practitioners’ MNGIE awareness thereby reducing the time to diagnosis, which in its turn improves the prognosis for the course of the disease for the patients.

9 August 2024 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
E(Elizaveta Makarova (Lapina)
Elizaveta Makarova (Lapina)
EAEkaterina Alexeeva
Ekaterina Alexeeva
OLO.L. Lomakina
O.L. Lomakina
TGT.V. Gabrusskaya
T.V. Gabrusskaya
NUN.B. Ulanova
N.B. Ulanova
Mikhail KostikMikhail Kostik
Mikhail Kostik
Vaccination of patients with immune-mediated diseases, such as inflammatory bowel diseases (IBD) and juvenile idiopathic arthritis (JIA), is an actual problem since these patients have an increased risk of developing infectious complications due to immunosuppressive therapy and features of the disease itself. The specialists’ attitude towards vaccination of patients with autoimmune inflammatory diseases has changed dramatically over the past decades: from complete refusal previously to almost complete implementation of the vaccine complex and the use of vaccines outside the national immunization schedule as of now. The purpose of this research was to assess the current attitude of pediatric gastroenterologists (PGs) and rheumatologists (PRs) towards vaccination of patients with IBD and JIA, to study their levels of knowledge and practical skills in this area using the anonymous online survey. Materials and methods used: an anonymous survey of 97 pediatric practitioners was conducted, of which 51 were PGs and 46 PRs. The questionnaire included questions about the physicians’ themselves (gender, experience, facility, academic degree) and their knowledge and approaches to vaccination of patients with IBD and JIA with live and inactivated vaccines during different stages of therapy. Results: most physicians believed that immune-inflammatory diseases are not provoked by vaccination (88% of PGs and 69.6% of PRs). A significant group of physicians (40.3% of PGs and 36.9% of PRs) consider vaccination with live vaccines safe for patients with IBD/JIA in remission while receiving immunosuppressive therapy. Most physicians consider vaccination with live vaccines unsafe in the state of active disease (80.4% of PGs and 71.8% of PRs). Outside of remission, physicians vaccinate such patients with live vaccines extremely rarely. A significant portion of physicians (32.0% of PGs and 21.7% of PRs) do not participate in vaccination considering it the responsibility of primary care pediatric practitioners/family physicians. Still, a significant portion of physicians (18.0% of PGs and 47.8% of PRs) actively discourage vaccination in general during the treatment of an immune-inflammatory disease. Determining antibodies to vaccines before starting immunosuppressive therapy/vaccination is considered appropriate by only 35.2%/47.0% of PGs and 32.5%/67.3% of PRs (р=0,885/0,110, respectively). Some physicians believe that vaccination can provoke an exacerbation of IBD/JIA (13.7%/21.6% of PGs and 21.7%/34.8% of PRs answered in affirmative or “rather yes than no,” respectively). Conclusion: the study revealed a differentiated attitude towards vaccination issues between PGs and PRs. Additional efforts needed in order to change the attitude of physicians of different specialties towards vaccination.